FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rolf Mueller

Research Profile

Living Beings

Mouse

Physiology

Concepts & Ideas

Molecular Sequence Data

Anatomy

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Josefine Stockert; Alexander Wolf; Sabine Müller-Brüsselbach; Evelyn Schnitzer; Florian Finkernagel; Kerstin Kaddatz; Michael Kracht; Wolfgang Meissner; Rolf Mueller
Regulation of TAK1/TAB1-Mediated IL-1β Signaling by Cytoplasmic PPARβ/δ.
Till Adhikary; Rolf Mueller
In Vivo Studies of PPAR-Chromatin Interactions: Chromatin Immunoprecipitation for Single-Locus and Genomewide Analyses.
Till Adhikary; Rolf Mueller
In vivo studies of PPAR-chromatin interactions: chromatin immunoprecipitation for single-locus and genomewide analyses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rolf Mueller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Josefine Stockert; Alexander Wolf; Sabine Müller-Brüsselbach; Evelyn Schnitzer; Florian Finkernagel; Kerstin Kaddatz; Michael Kracht; Wolfgang Meissner; Rolf Mueller
Regulation of TAK1/TAB1-Mediated IL-1β Signaling by Cytoplasmic PPARβ/δ.
PloS one 2013;8(4):e63011.
2013: Till Adhikary; Rolf Mueller
In Vivo Studies of PPAR-Chromatin Interactions: Chromatin Immunoprecipitation for Single-Locus and Genomewide Analyses.
Methods in molecular biology (Clifton, N.J.) 2013;952():E1.
2013: Till Adhikary; Rolf Mueller
In vivo studies of PPAR-chromatin interactions: chromatin immunoprecipitation for single-locus and genomewide analyses.
Methods in molecular biology (Clifton, N.J.) 2013;952():175-85.
2012: Sonja Lieber; Wolfgang Meissner; Till Adhikary; Wibke E Diederich; Sabine Müller-Brüsselbach; Simone Naruhn; Frithjof Scheer; Rolf Mueller
(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
Journal of medicinal chemistry 2012;55(6):2858-68.
2011: Simone Naruhn; Veronika Pape; Philipp M Toth; Sabine Müller-Brüsselbach; Till Adhikary; Wibke E Diederich; Stefanie Dörr; Kerstin Kaddatz; Gerhard Klebe; Rolf Mueller
High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
Molecular pharmacology 2011;80(5):828-38.
2011: Edyta Stec; Rolf Mueller; Dominik Pistorius; Shu-Ming Li
AuaA, a membrane-bound farnesyltransferase from Stigmatella aurantiaca, catalyzes the prenylation of 2-methyl-4-hydroxyquinoline in the biosynthesis of aurachins.
Chembiochem : a European journal of chemical biology 2011;12(11):1724-30.
2011: Till Adhikary; Kerstin Kaddatz; Florian Finkernagel; Anne Schönbauer; Wolfgang Meissner; Maren Scharfe; Michael Jarek; Helmut Blöcker; Sabine Müller-Brüsselbach; Rolf Mueller
Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ).
PloS one 2011;6(1):e16344.
2011: Josefine Stockert; Till Adhikary; Kerstin Kaddatz; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Rolf Mueller
Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling.
Nucleic acids research 2011;39(1):119-31.
2010: Kerstin Kaddatz; Till Adhikary; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Rolf Mueller
Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription.
The Journal of biological chemistry 2010;285(38):29469-79.
2010: Simone Naruhn; Wolfgang Meissner; Till Adhikary; Kerstin Kaddatz; T Klein; Bernhard Watzer; Sabine Müller-Brüsselbach; Rolf Mueller
15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
Molecular pharmacology 2010;77(2):171-84.
2009: Rolf Mueller; B Heber; T Hashimoto; G Messer; R Müllegger; Andrea Niedermeier; Michael Hertl
Autoantibodies against desmocollins in European patients with pemphigus.
Clinical and experimental dermatology 2009;34(8):898-903.
2009: Susanne Wiegand; Branka Dakic; Ariane F E Rath; Galina Makarova; Carolina Sterz; Wolfgang Meissner; Michael Bette; Jürgen Adamkiewicz; Sabine Müller-Brüsselbach; Rolf Mueller; Jochen A Werner; Robert Mandic
The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas.
Oral oncology 2009;45(10):e140-9.
2008: Markus Rieck; Wolfgang Meissner; Simone Ries; Sabine Müller-Brüsselbach; Rolf Mueller
Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Molecular pharmacology 2008;74(5):1269-77.
2008: Rolf Mueller; Markus Rieck; Sabine Müller-Brüsselbach
Regulation of Cell Proliferation and Differentiation by PPARbeta/delta.
PPAR research 2008;2008():614852.
2008: Rolf Mueller; Martin Kömhoff; Jeffrey M Peters; Sabine Müller-Brüsselbach
A Role for PPARbeta/delta in Tumor Stroma and Tumorigenesis.
PPAR research 2008;2008():534294.
2007: Markus Rieck; Lena Wedeken; Sabine Müller-Brüsselbach; Wolfgang Meissner; Rolf Mueller
Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor beta.
The FEBS journal 2007;274(19):5068-76.
2007: Sabine Müller-Brüsselbach; Schokufe Ebrahimsade; Jörg Jäkel; Jenny Eckhardt; Ulf R Rapp; Jeffrey M Peters; Roland Moll; Rolf Mueller
Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARbeta/delta gene.
International journal of oncology 2007;31(3):607-11.
2007: Sabine Müller-Brüsselbach; Martin Kömhoff; Markus Rieck; Wolfgang Meissner; Kerstin Kaddatz; Jürgen Adamkiewicz; Boris Keil; Klaus Jochen Klose; Roland Moll; Andrew D Burdick; Jeffrey M Peters; Rolf Mueller
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice.
The EMBO journal 2007;26(15):3686-98.
2007: Mihaela Kreutzer; Tanja Fauti; Kerstin Kaddatz; Carola Seifart; Andreas Neubauer; Horst Schweer; Martin Kömhoff; Sabine Müller-Brüsselbach; Rolf Mueller
Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
Oncology reports 2007;18(2):497-501.
2007: Jürgen Adamkiewicz; Kerstin Kaddatz; Markus Rieck; Bernhard Wilke; Sabine Müller-Brüsselbach; Rolf Mueller
Proteomic profile of mouse fibroblasts with a targeted disruption of the peroxisome proliferator activated receptor-beta/delta gene.
Proteomics 2007;7(8):1208-16.
2006: Valérie Jérôme; Andreas Graser; Rolf Mueller; Roland Kontermann; Abdo Konur
Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(3):294-305.
2006: Tanja Fauti; Sabine Müller-Brüsselbach; Mihaela Kreutzer; Markus Rieck; Wolfgang Meissner; Ulf R Rapp; Horst Schweer; Martin Kömhoff; Rolf Mueller
Induction of PPARbeta and prostacyclin (PGI2) synthesis by Raf signaling: failure of PGI2 to activate PPARbeta.
The FEBS journal 2006;273(1):170-9.
2005: Anne Kienitz; Celia Vogel; Ivonne Morales; Rolf Mueller; Holger Bastians
Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol.
Oncogene 2005;24(26):4301-10.
2005: Celia Vogel; Anne Kienitz; Rolf Mueller; Holger Bastians
The mitotic spindle checkpoint is a critical determinant for topoisomerase-based chemotherapy.
The Journal of biological chemistry 2005;280(6):4025-8.
2005: Tina Völkel; Hans-Heinrich Heidtmann; Rolf Mueller; Roland Kontermann
Engineering of human coagulation factor x variants activated by prostate-specific antigen.
Molecular biotechnology 2005;29(1):19-30.
2004: Celia Vogel; Anne Kienitz; Irmgard Hofmann; Rolf Mueller; Holger Bastians
Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.
Oncogene 2004;23(41):6845-53.
2004: Rolf Mueller
Crosstalk of oncogenic and prostanoid signaling pathways.
Journal of cancer research and clinical oncology 2004;130(8):429-44.
2004: Tina Korn; Dirk M Nettelbeck; Tina Völkel; Rolf Mueller; Roland Kontermann
Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv.
The journal of gene medicine 2004;6(6):642-51.
2004: Tina Völkel; Peter Hölig; Thomas Merdan; Rolf Mueller; Roland Kontermann
Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).
Biochimica et biophysica acta 2004;1663(1-2):158-66.
2004: Peter Hölig; Miriam Bach; Tina Völkel; Thomas Nahde; Sven Hoffmann; Rolf Mueller; Roland Kontermann
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.
Protein engineering, design & selection : PEDS 2004;17(5):433-41.
2004: Johannes T Heverhagen; Andreas Graser; Alfred Fahr; Rolf Mueller; Heiko Alfke
Encapsulation of gadobutrol in AVE-based liposomal carriers for MR detectability.
Magnetic resonance imaging 2004;22(4):483-7.
2004: Andreas Burchert; Dali Cai; Lorenz C Hofbauer; Magnus K R Samuelsson; Emily P Slater; Justus Duyster; Markus Ritter; Andreas Hochhaus; Rolf Mueller; Martin Eilers; Manuel Schmidt; Andreas Neubauer
Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.
Blood 2004;103(9):3480-9.
2004: Tina Völkel; Rolf Mueller; Roland Kontermann
Isolation of endothelial cell-specific human antibodies from a novel fully synthetic scFv library.
Biochemical and biophysical research communications 2004;317(2):515-21.
2004: Tina Korn; Rolf Mueller; Roland Kontermann
Bispecific single-chain diabody-mediated killing of endoglin-positive endothelial cells by cytotoxic T lymphocytes.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(2):99-106.
2004: Thomas Duerfahrt; Katrin Eppelmann; Rolf Mueller; Mohamed A Marahiel
Rational design of a bimodular model system for the investigation of heterocyclization in nonribosomal peptide biosynthesis.
Chemistry & biology 2004;11(2):261-71.
2003: Stephan Gehrke; Valérie Jérôme; Rolf Mueller
Chimeric transcriptional control units for improved liver-specific transgene expression.
Gene 2003;322():137-43.
2003: Miriam Bach; Peter Hölig; Eva Schlosser; Tina Völkel; Andreas Graser; Rolf Mueller; Roland Kontermann
Isolation from phage display libraries of lysine-deficient human epidermal growth factor variants for directional conjugation as targeting ligands.
Protein engineering 2003;16(12):1107-13.
2003: Silvia Montigiani; Rolf Mueller; Roland Kontermann
Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2F.
Oncogene 2003;22(32):4943-52.
2003: Emily P Slater; Thomas Stübig; Quek Choon Lau; Tatjana V Achenbach; Ulf R Rapp; Rolf Mueller
C-Raf controlled pathways in the protection of tumor cells from apoptosis.
International journal of cancer. Journal international du cancer 2003;104(4):425-32.
2002: Alfred Fahr; K Müller; Th Nahde; Rolf Mueller; Sabine Brüsselbach
A new colloidal lipidic system for gene therapy.
Journal of liposome research 2002;12(1-2):37-44.
2002: Quek Choon Lau; Tatjana V Achenbach; Oliver Borchers; Rolf Mueller; Emily P Slater
In vivo pro-apoptotic and antitumor efficacy of a c-Raf antisense phosphorothioate oligonucleotide: relationship to tumor size.
Antisense & nucleic acid drug development 2002;12(1):11-20.
2001: Tina Völkel; Tina Korn; Miriam Bach; Rolf Mueller; Roland Kontermann
Optimized linker sequences for the expression of monomeric and dimeric bispecific single-chain diabodies.
Protein engineering 2001;14(10):815-23.
2001: Th Nahde; K Müller; Alfred Fahr; Rolf Mueller; Sabine Brüsselbach
Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles.
The journal of gene medicine 2001;3(4):353-61.
2001: D Heine; Rolf Mueller; Sabine Brüsselbach
Cell surface display of a lysosomal enzyme for extracellular gene-directed enzyme prodrug therapy.
Gene therapy 2001;8(13):1005-10.
2001: Dirk M Nettelbeck; D W Miller; Valérie Jérôme; Marylou Zuzarte; SJ Watkins; Robert E Hawkins; Rolf Mueller; Roland Kontermann
Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(6):882-91.
2001: Valérie Jérôme; Rolf Mueller
A synthetic leucine zipper-based dimerization system for combining multiple promoter specificities.
Gene therapy 2001;8(9):725-9.
2001: K Körner; V Jerôme; T Schmidt; Rolf Mueller
Cell cycle regulation of the murine cdc25B promoter: essential role for nuclear factor-Y and a proximal repressor element.
The Journal of biological chemistry 2001;276(13):9662-9.
2001: K Müller; Th Nahde; Alfred Fahr; Rolf Mueller; Sabine Brüsselbach
Highly efficient transduction of endothelial cells by targeted artificial virus-like particles.
Cancer gene therapy 2001;8(2):107-17.
2001: B Fernandez Pujol; FC Lucibello; Marylou Zuzarte; P Lütjens; Rolf Mueller; Klaus Havemann
Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells.
European journal of cell biology 2001;80(1):99-110.
2000: Tatjana V Achenbach; Rolf Mueller; Emily P Slater
Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release.
The Journal of biological chemistry 2000;275(41):32089-97.
2000: Tatjana V Achenbach; Emily P Slater; H Brummerhop; Thorsten Bach; Rolf Mueller
Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells.
Antimicrobial agents and chemotherapy 2000;44(10):2794-801.
2000: Tatjana V Achenbach; Rolf Mueller; Emily P Slater
Synergistic antitumor effect of chemotherapy and antisense-mediated ablation of the cell cycle inhibitor p27KIP-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3006-14.
2000: K Körner; Rolf Mueller
In vivo structure of the cell cycle-regulated human cdc25C promoter.
The Journal of biological chemistry 2000;275(25):18676-81.
2000: B Fernandez Pujol; FC Lucibello; U M Gehling; K Lindemann; N Weidner; Marylou Zuzarte; Jürgen Adamkiewicz; Hans-Peter Elsässer; Rolf Mueller; Klaus Havemann
Endothelial-like cells derived from human CD14 positive monocytes.
Differentiation; research in biological diversity 2000;65(5):287-300.
2000: Dirk M Nettelbeck; Valérie Jérôme; Rolf Mueller
Gene therapy: designer promoters for tumour targeting.
Trends in genetics : TIG 2000;16(4):174-81.
2000: D Weyel; HH Sedlacek; Rolf Mueller; Sabine Brüsselbach
Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy.
Gene therapy 2000;7(3):224-31.
1999: M Alt; Rolf Mueller; Roland Kontermann
Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin gamma1 Fc or CH3 region.
FEBS letters 1999;454(1-2):90-4.
1999: Dirk M Nettelbeck; Valérie Jérôme; Rolf Mueller
A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control.
Gene therapy 1999;6(7):1276-81.
1999: Roland Kontermann; Rolf Mueller
Intracellular and cell surface displayed single-chain diabodies.
Journal of immunological methods 1999;226(1-2):179-88.
1999: D W Miller; W Graulich; B Karges; S Stahl; M Ernst; Annette Ramaswamy; HH Sedlacek; Rolf Mueller; Jürgen Adamkiewicz
Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells.
International journal of cancer. Journal international du cancer 1999;81(4):568-72.
1999: J Zwicker; K Körner; Rolf Mueller
The SV40 large T oncoprotein disrupts DNA-binding of the cell cycle-regulated transcriptional repressor CDF.
Oncogene 1999;18(11):2023-5.
1999: W Graulich; Dirk M Nettelbeck; D Fischer; T Kissel; Rolf Mueller
Cell type specificity of the human endoglin promoter.
Gene 1999;227(1):55-62.
1999: J Zwicker; Sabine Brüsselbach; K U Jooss; Sewing Andreas; Moira Behn; FC Lucibello; Rolf Mueller
Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation.
Oncogene 1999;18(1):19-25.
1998: Valérie Jérôme; Rolf Mueller
Tissue-specific, cell cycle-regulated chimeric transcription factors for the targeting of gene expression to tumor cells.
Human gene therapy 1998;9(18):2653-9.
1998: Dirk M Nettelbeck; Valérie Jérôme; Rolf Mueller
A strategy for enhancing the transcriptional activity of weak cell type-specific promoters.
Gene therapy 1998;5(12):1656-64.
1998: Sabine Brüsselbach; Dirk M Nettelbeck; HH Sedlacek; Rolf Mueller
Cell cycle-independent induction of apoptosis by the anti-tumor drug Flavopiridol in endothelial cells.
International journal of cancer. Journal international du cancer 1998;77(1):146-52.
1998: N Liu; FC Lucibello; Kurt Engeland; Rolf Mueller
A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F.
Oncogene 1998;16(23):2957-63.
1998: Quek Choon Lau; Sabine Brüsselbach; Rolf Mueller
Abrogation of c-Raf expression induces apoptosis in tumor cells.
Oncogene 1998;16(14):1899-902.
1998: J Zwicker; FC Lucibello; Valérie Jérôme; Sabine Brüsselbach; Rolf Mueller
CDF-1 mediated repression of cell cycle genes targets a specific subset of transactivators.
Nucleic acids research 1998;26(4):4926-32.
1998: Dirk M Nettelbeck; J Zwicker; FC Lucibello; C Gross; N Liu; Sabine Brüsselbach; Rolf Mueller
Cell cycle regulated promoters for the targeting of tumor endothelium.
Advances in experimental medicine and biology 1998;451():437-40.
1998: Jörg Kaufmann; K Ahrens; Ronald Koop; S T Smale; Rolf Mueller
CIF150, a human cofactor for transcription factor IID-dependent initiator function.
Molecular and cellular biology 1998;18(1):233-9.
1997: K Körner; L A Wolfraim; FC Lucibello; Rolf Mueller
Characterization of the TATA-less core promoter of the cell cycle-regulated cdc25C gene.
Nucleic acids research 1997;25(24):4933-9.
1997: J Zwicker; FC Lucibello; Valérie Jérôme; Sabine Brüsselbach; Rolf Mueller
CDF-1-mediated repression of cell cycle genes targets a specific subset of transactivators.
Nucleic acids research 1997;25(24):4926-32.
1997: FC Lucibello; N Liu; J Zwicker; C Gross; Rolf Mueller
The differential binding of E2F and CDF repressor complexes contributes to the timing of cell cycle-regulated transcription.
Nucleic acids research 1997;25(24):4921-5.
1997: N Liu; FC Lucibello; K Körner; L A Wolfraim; J Zwicker; Rolf Mueller
CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.
Nucleic acids research 1997;25(24):4915-20.
1997: Dominik Mumberg; M Wick; C Bürger; K Haas; Martin Funk; Rolf Mueller
Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation.
Nucleic acids research 1997;25(11):2098-105.
1997: Martin Funk; B Poensgen; W Graulich; V Jerome; Rolf Mueller
A novel, transformation-relevant activation domain in Fos proteins.
Molecular and cellular biology 1997;17(2):537-44.
1997: J Zwicker; Rolf Mueller
Cell-cycle regulation of gene expression by transcriptional repression.
Trends in genetics : TIG 1997;13(1):3-6.
1996: Dominik Mumberg; K Haas; Tarik Möröy; R Niedenthal; Johannes H Hegemann; Martin Funk; Rolf Mueller
Uncoupling of DNA replication and cell cycle progression by human cyclin E.
Oncogene 1996;13(11):2493-7.
1996: N Liu; FC Lucibello; J Zwicker; Kurt Engeland; Rolf Mueller
Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element.
Nucleic acids research 1996;24(15):2905-10.
1996: R Mazhari-Tabrizi; Volker Eckert; M Blank; Rolf Mueller; Dominik Mumberg; Martin Funk; Ralph T Schwarz
Cloning and functional expression of glycosyltransferases from parasitic protozoans by heterologous complementation in yeast: the dolichol phosphate mannose synthase from Trypanosoma brucei brucei.
The Biochemical journal 1996;316 ( Pt 3)():853-8.
1996: J Zwicker; N Liu; Kurt Engeland; FC Lucibello; Rolf Mueller
Cell cycle regulation of E2F site occupation in vivo.
Science (New York, N.Y.) 1996;271(5255):1595-7.
1995: M Wick; R Härönen; Dominik Mumberg; C Bürger; B R Olsen; M L Budarf; S S Apte; Rolf Mueller
Structure of the human TIMP-3 gene and its cell cycle-regulated promoter.
The Biochemical journal 1995;311 ( Pt 2)():549-54.
1995: J Zwicker; C Gross; FC Lucibello; M Truss; F Ehlert; Kurt Engeland; Rolf Mueller
Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1.
Nucleic acids research 1995;23(19):3822-30.
1995: J Zwicker; FC Lucibello; L A Wolfraim; C Gross; M Truss; Kurt Engeland; Rolf Mueller
Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression.
The EMBO journal 1995;14(18):4514-22.
1995: M Wick; C Bürger; Martin Funk; Rolf Mueller
Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation.
Experimental cell research 1995;219(2):527-35.
1995: Rolf Mueller
Transcriptional regulation during the mammalian cell cycle.
Trends in genetics : TIG 1995;11(5):173-8.
1995: Dominik Mumberg; Rolf Mueller; Martin Funk
Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds.
Gene 1995;156(1):119-22.
1995: G Irmer; C Bürger; Rolf Mueller; Olaf Ortmann; U Peter; S S Kakar; Jimmy Neill; Klaus-Dieter Schulz; G Emons
Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma.
Cancer research 1995;55(4):817-22.
1995: K U Jooss; Rolf Mueller
Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation.
Oncogene 1995;10(3):603-8.
1995: Sabine Brüsselbach; U Möhle-Steinlein; Z Q Wang; M Schreiber; FC Lucibello; Rolf Mueller; E F Wagner
Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos.
Oncogene 1995;10(1):79-86.
1995: FC Lucibello; M Truss; J Zwicker; F Ehlert; Miguel Beato; Rolf Mueller
Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE).
The EMBO journal 1995;14(1):132-42.
1995: J Zwicker; Rolf Mueller
Cell cycle-regulated transcription in mammalian cells.
Progress in cell cycle research 1995;1():91-9.
1994: Dominik Mumberg; Rolf Mueller; Martin Funk
Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression.
Nucleic acids research 1994;22(25):5767-8.
1994: Sewing Andreas; Rolf Mueller
Protein kinase A phosphorylates cyclin D1 at three distinct sites within the cyclin box and at the C-terminus.
Oncogene 1994;9(9):2733-6.
1994: M Wick; C Bürger; Sabine Brüsselbach; FC Lucibello; Rolf Mueller
A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence.
The Journal of biological chemistry 1994;269(29):18953-60.
1994: C Bürger; M Wick; Rolf Mueller
Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells.
Journal of cell science 1994;107 ( Pt 7)():2047-54.
1994: B Herber; M Truss; Miguel Beato; Rolf Mueller
Inducible regulatory elements in the human cyclin D1 promoter.
Oncogene 1994;9(4):1295-304.
1994: K U Jooss; M Funk; Rolf Mueller
An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation.
The EMBO journal 1994;13(6):1467-75.
1994: Anja Wimmel; FC Lucibello; Sewing Andreas; S Adolph; Rolf Mueller
Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E.
Oncogene 1994;9(3):995-7.
1994: M Wick; C Bürger; Sabine Brüsselbach; FC Lucibello; Rolf Mueller
Identification of serum-inducible genes: different patterns of gene regulation during G0-->S and G1-->S progression.
Journal of cell science 1994;107 ( Pt 3)():preceding table of contents.
1994: S Adolph; Rolf Mueller
Different fate of sibling cells upon inhibition of transcription in G1.
Experimental cell research 1994;210(2):349-52.
1994: Sewing Andreas; V Rönicke; C Bürger; Martin Funk; Rolf Mueller
Alternative splicing of human cyclin E.
Journal of cell science 1994;107 ( Pt 2)():581-8.
1994: H Lovec; Sewing Andreas; FC Lucibello; Rolf Mueller; Tarik Möröy
Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
Oncogene 1994;9(1):323-6.
1994: M Wick; C Bürger; Sabine Brüsselbach; FC Lucibello; Rolf Mueller
Identification of serum-inducible genes: different patterns of gene regulation during G0-->S and G1-->S progression.
Journal of cell science 1994;107 ( Pt 1)():227-39.
1994: P Bierbaum; S MacLean-Hunter; F Ehlert; Tarik Möröy; Rolf Mueller
Cloning of embryonal stem cell-specific genes: characterization of the transcriptionally controlled gene esg-1.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(1):37-46.
1994: C Bürger; M Wick; Sabine Brüsselbach; Rolf Mueller
Differential induction of 'metabolic genes' after mitogen stimulation and during normal cell cycle progression.
Journal of cell science 1994;107 ( Pt 1)():241-52.
1993: Marcus Schuermann; G Hennig; Rolf Mueller
Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion.
Oncogene 1993;8(10):2781-90.
1993: Rolf Mueller; Dominik Mumberg; FC Lucibello
Signals and genes in the control of cell-cycle progression.
Biochimica et biophysica acta 1993;1155(2):151-79.
1993: FC Lucibello; Sabine Brüsselbach; Sewing Andreas; Rolf Mueller
Suppression of the growth factor-mediated induction of c-fos and down-modulation of AP-1-binding activity are not required for cellular senescence.
Oncogene 1993;8(6):1667-72.
1993: FC Lucibello; Sewing Andreas; Sabine Brüsselbach; C Bürger; Rolf Mueller
Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts.
Journal of cell science 1993;105 ( Pt 1)():123-33.
1993: S Adolph; Sabine Brüsselbach; Rolf Mueller
Inhibition of transcription blocks cell cycle progression of NIH3T3 fibroblasts specifically in G1.
Journal of cell science 1993;105 ( Pt 1)():113-22.
1993: Sewing Andreas; C Bürger; Sabine Brüsselbach; C Schalk; FC Lucibello; Rolf Mueller
Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP.
Journal of cell science 1993;104 ( Pt 2)():545-55.
1992: K Jooss; Rolf Mueller
Analysis of temperature-sensitive functions of Fos: lack of a correlation between transformation and TRE-dependent trans-activation.
Oncogene 1992;7(10):1933-9.
1992: H Sartor; F Ehlert; Karl-Heinz Grzeschik; Rolf Mueller; S Adolph
Assignment of two human cell cycle genes, CDC25C and CCNB1, to 5q31 and 5q12, respectively.
Genomics 1992;13(3):911-2.
1992: M Wick; FC Lucibello; Rolf Mueller
Inhibition of Fos- and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains.
Oncogene 1992;7(5):859-67.
1992: FC Lucibello; Rolf Mueller
Transcription factor encoding oncogenes.
Reviews of physiology, biochemistry and pharmacology 1992;119():225-57.
1991: M Neuberg; Marcus Schuermann; Rolf Mueller
Mutagenesis of the DNA contact site in Fos protein: compatibility with the scissors grip model and requirement for transformation.
Oncogene 1991;6(8):1325-33.
1991: FC Lucibello; F Ehlert; Rolf Mueller
Multiple interdependent regulatory sites in the mouse c-fos promoter determine basal level transcription: cell type-specific effects.
Nucleic acids research 1991;19(13):3583-91.
1991: FC Lucibello; M Neuberg; T Jenuwein; Rolf Mueller
Multiple regions of v-Fos protein involved in the activation of AP1-dependent transcription: is trans-activation crucial for transformation?
The New biologist 1991;3(7):671-7.
1991: Dominik Mumberg; FC Lucibello; Marcus Schuermann; Rolf Mueller
Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins.
Genes & development 1991;5(7):1212-23.
1991: Marcus Schuermann; K Jooss; Rolf Mueller
fosB is a transforming gene encoding a transcriptional activator.
Oncogene 1991;6(4):567-76.
1991: Marcus Schuermann; J B Hunter; G Hennig; Rolf Mueller
Non-leucine residues in the leucine repeats of Fos and Jun contribute to the stability and determine the specificity of dimerization.
Nucleic acids research 1991;19(4):739-46.
1991: B Redemann-Fibi; Marcus Schuermann; Rolf Mueller
Stage and tissue-specific expression of fosB during mouse development.
Differentiation; research in biological diversity 1991;46(1):43-9.
1991: FC Lucibello; Rolf Mueller
Proto-oncogenes encoding transcriptional regulators: unravelling the mechanisms of oncogenic conversion.
Critical reviews in oncogenesis 1991;2(4):259-76.
1990: FC Lucibello; E P Slater; K U Jooss; Miguel Beato; Rolf Mueller
Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB.
The EMBO journal 1990;9(9):2827-34.
1990: G Risse; M Neuberg; J B Hunter; Bernard Verrier; Rolf Mueller
Products of the fos and jun proto-oncogenes bind cooperatively to the AP1 DNA recognition sequence.
Environmental health perspectives 1990;88():133-9.
1990: Jürgen Adamkiewicz; H J Brüller; H Gausepohl; R Frank; Rolf Mueller
Mapping of functional domains in Fos and Jun proteins using epitope-specific antibodies.
Oncogene 1990;5(4):525-33.
1989: FC Lucibello; C Lowag; M Neuberg; Rolf Mueller
trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation.
Cell 1989;59(6):999-1007.
1989: G Risse; K Jooss; M Neuberg; H J Brüller; Rolf Mueller
Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes.
The EMBO journal 1989;8(12):3825-32.
1989: M Neuberg; Jürgen Adamkiewicz; J B Hunter; Rolf Mueller
A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
Nature 1989;341(6239):243-5.
1989: M Neuberg; Marcus Schuermann; J B Hunter; Rolf Mueller
Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex.
Nature 1989;338(6216):589-90.
1989: Marcus Schuermann; M Neuberg; J B Hunter; T Jenuwein; Rolf-Peter Ryseck; R Bravo; Rolf Mueller
The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation.
Cell 1989;56(3):507-16.